332.9000 -15.60 (-4.48%)
NSE Apr 04, 2025 15:31 PM
Volume: 286.1K
 

332.90
-4.48%
Axis Direct
We expect revenue and PAT CAGR of 15.9% and 15.3% respectively over the period FY21-FY23E and recommend a Buy with TP of INR 840.
Aarti Drugs Ltd. has lost -29.87% in the last 1 Year
More from Aarti Drugs Ltd.
All earning calls
Investor presentations from Aarti Drugs Ltd.
All investor presentations